3-aminobenzamide has been researched along with Infarction, Middle Cerebral Artery in 3 studies
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S | 1 |
| Kaul, CL | 1 |
| Sharma, SS | 1 |
| Koh, SH | 1 |
| Park, Y | 1 |
| Song, CW | 1 |
| Kim, JG | 1 |
| Kim, K | 1 |
| Kim, J | 1 |
| Kim, MH | 1 |
| Lee, SR | 1 |
| Kim, DW | 1 |
| Yu, HJ | 1 |
| Chang, DI | 1 |
| Hwang, SJ | 1 |
| Kim, SH | 1 |
| Ding, Y | 1 |
| Zhou, Y | 1 |
| Lai, Q | 1 |
| Li, J | 1 |
| Gordon, V | 1 |
| Diaz, FG | 1 |
3 other studies available for 3-aminobenzamide and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
Topics: Animals; Antioxidants; Benzamides; Brain Ischemia; Disease Models, Animal; Drug Combinations; Drug T | 2004 |
The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
Topics: Animals; Benzamides; Blotting, Western; Brain; Brain Edema; Brain Infarction; Brain Ischemia; Caspas | 2004 |
Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
Topics: Animals; Benzamides; Cerebral Infarction; Cerebrovascular Circulation; Enzyme Inhibitors; Female; In | 2001 |